Successful Treatment of a Pacemaker Infection with Intraperitoneal Daptomycin

Anne B Taegtmeyer1, Nina Kononowa2, Dominique Fasel3

  • 1Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.

Insights

Intraperitoneal daptomycin effectively treats infections in peritoneal dialysis patients. Careful therapeutic drug monitoring and dose adjustments are crucial for achieving optimal daptomycin serum concentrations.

Area of Science:

  • Pharmacology
  • Nephrology
  • Infectious Diseases

Background:

  • Daptomycin is a crucial antibiotic for treating Gram-positive infections, including those caused by Staphylococcus epidermidis.
  • Peritoneal dialysis (PD) patients present unique challenges for antibiotic dosing due to altered drug pharmacokinetics.
  • Intraperitoneal (IP) administration offers a potential alternative route for antibiotic delivery in PD patients.

Observation:

  • A single PD patient with a pacemaker infection was treated with intravenous, then intraperitoneal daptomycin.
  • The initial IP daptomycin dose of 5.3 mg/kg every 48 hours resulted in supratherapeutic peak serum concentrations.
  • Therapeutic drug monitoring (TDM) guided a dose reduction to 3.2 mg/kg every 48 hours.

Findings:

  • Intraperitoneal daptomycin administration achieved serum concentrations above the minimal inhibitory concentration (MIC) in a PD patient.
  • Lower IP daptomycin doses may be sufficient compared to standard intravenous recommendations.
  • Serum drug concentration monitoring and dose adjustments are essential for safe and effective IP daptomycin therapy.

Implications:

  • Intraperitoneal daptomycin is a viable option for treating PD patients with specific infections.
  • Pharmacokinetic variability necessitates individualized dosing and TDM for IP daptomycin.
  • This case highlights the importance of adapting antibiotic strategies for PD patients to ensure therapeutic efficacy and safety.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
329
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
494
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
628
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
40
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.0K
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
564